| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
787,100,000 |
| Market
Cap: |
85.20(B) |
| Last
Volume: |
191,226,646 |
Avg
Vol: |
88,707,916 |
| 52
Week Range: |
$108.24 - $108.24 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
NASDAQ-100 |
| |
S&P 500 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ahmed Nadim |
PRES., HEMATOLOGY AND ONCOLOGY |
• – – |
2019-05-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,563 |
13,124 |
|
- |
|
| Curran Terrie |
SEE REMARKS |
• – – |
2019-05-02 |
4 |
D |
$95.21 |
$46,653 |
D/D |
(490) |
8,993 |
|
- |
|
| Curran Terrie |
SEE REMARKS |
• – – |
2019-05-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,563 |
9,483 |
|
- |
|
| Alles Mark J |
CEO, CHAIRMAN OF BOARD |
• • – |
2019-05-02 |
4 |
D |
$95.21 |
$630,290 |
D/D |
(6,620) |
221,266 |
|
- |
|
| Alles Mark J |
CEO, CHAIRMAN OF BOARD |
• • – |
2019-05-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,608 |
227,886 |
|
- |
|
| Mario Ernest |
|
– • – |
2019-03-05 |
4 |
A |
$85.97 |
$250,001 |
I/I |
2,908 |
4,908 |
|
- |
|
| Mario Ernest |
|
– • – |
2019-03-05 |
4 |
D |
$85.97 |
$250,001 |
D/D |
(2,908) |
55,005 |
|
- |
|
| Alles Mark J |
CEO, CHAIRMAN OF BOARD |
• • – |
2019-03-01 |
4 |
D |
$85.96 |
$1,194,844 |
D/D |
(13,900) |
212,278 |
|
- |
|
| Alles Mark J |
CEO, CHAIRMAN OF BOARD |
• • – |
2019-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,809 |
226,178 |
|
- |
|
| Mario Ernest |
|
– • – |
2019-02-12 |
4 |
B |
$89.99 |
$179,980 |
I/I |
2,000 |
2,000 |
0.01 |
- |
|
| Loughlin James J |
|
– • – |
2019-02-07 |
4 |
S |
$87.29 |
$2,048,324 |
D/D |
(23,466) |
38,636 |
|
- |
|
| Loughlin James J |
|
– • – |
2019-02-07 |
4 |
OE |
$22.47 |
$554,245 |
D/D |
24,666 |
62,102 |
|
- |
|
| Mario Ernest |
|
– • – |
2019-01-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,100 |
57,913 |
|
- |
|
| Mario Ernest |
|
– • – |
2018-12-19 |
4 |
OE |
$59.06 |
$507,873 |
D/D |
8,600 |
63,013 |
|
- |
|
| Curran Terrie |
SEE REMARKS |
• – – |
2018-12-16 |
4 |
D |
$68.20 |
$83,954 |
D/D |
(1,231) |
7,920 |
|
- |
|
| Curran Terrie |
SEE REMARKS |
• – – |
2018-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
9,151 |
|
- |
|
| Alles Mark J |
CEO, CHAIRMAN OF BOARD |
• • – |
2018-12-16 |
4 |
D |
$68.20 |
$264,343 |
D/D |
(3,876) |
192,369 |
|
- |
|
| Alles Mark J |
CEO, CHAIRMAN OF BOARD |
• • – |
2018-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,929 |
196,245 |
|
- |
|
| Ahmed Nadim |
PRES., HEMATOLOGY AND ONCOLOGY |
• – – |
2018-12-16 |
4 |
D |
$68.20 |
$100,731 |
D/D |
(1,477) |
11,561 |
|
- |
|
| Ahmed Nadim |
PRES., HEMATOLOGY AND ONCOLOGY |
• – – |
2018-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
13,038 |
|
- |
|
| Biller Jonathan |
EVP AND GENERAL COUNSEL |
• – – |
2018-12-16 |
4 |
D |
$68.20 |
$63,767 |
D/D |
(935) |
3,111 |
|
- |
|
| Biller Jonathan |
EVP AND GENERAL COUNSEL |
• – – |
2018-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,900 |
4,046 |
|
- |
|
| Vessey Rupert |
SEE REMARKS |
• – – |
2018-12-16 |
4 |
D |
$68.20 |
$179,639 |
D/D |
(2,634) |
7,253 |
|
- |
|
| Vessey Rupert |
SEE REMARKS |
• – – |
2018-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,350 |
9,887 |
|
- |
|
| Mario Ernest |
|
– • – |
2018-11-26 |
4 |
OE |
$59.06 |
$590,550 |
D/D |
10,000 |
54,413 |
|
- |
|
956 Records found
|
|
Page 4 of 39 |
|
|
